Search

Hansson, Oskar
 
Advanced search
Browse by...
Refine your research by the most used items

Author / Editor

Document type

Full text accessibility

Full text version

Licence

Subject

Deposit
Highlights
More informations
Show items per page
Elements: 9
Page 1 on 1
 TitleAuthors / EditorsDate
add to browser selection
 Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects Toledo, Jon B.; Zetterberg, Henrik; van Harten, Argonde C.; Glodzik, Lidia; ... Trojanowski, John Q. 2015
add to browser selection
 Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias Chételat, Gaël; Arbizu, Javier; Barthel, Henryk; Garibotto, Valentina; ... Drzezga, Alexander 2020
add to browser selection
 Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study van Maurik, Ingrid S; Vos, Stephanie J; Bos, Isabelle; Bouwman, Femke H; ... van der Flier, Wiesje M 2019
add to browser selection
 Clinical validity of cerebrospinal fluid Aβ42, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework Mattsson, Niklas; Lönneborg, Anders; Boccardi, Marina; Blennow, Kaj; Hansson, Oskar 2017
add to browser selection
 Clinical validity of CSF biomarkers for Alzheimer's disease: necessary indeed, but sufficient? Frisoni, Giovanni; Hansson, Oskar 2016
add to browser selection
 Clinical validity of increased cortical binding of tau ligands of the THK family and PBB3 on PET as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework Chiotis, Konstantinos; Dodich, Alessandra; Boccardi, Marina; Festari, Cristina; ... Nordberg, Agneta 2021
add to browser selection
 Clinical validity of second-generation tau PET tracers as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework Bischof, Gérard N; Dodich, Alessandra; Boccardi, Marina; van Eimeren, Thilo; ... Drzezga, Alexander 2021
add to browser selection
 Preclinical effects of APOE ε4 on cerebrospinal fluid Aβ42 concentrations Lautner, Ronald; Insel, Philip S; Skillbäck, Tobias; Olsson, Bob; ... Zetterberg, Henrik 2017
add to browser selection
 The strategic biomarker roadmap for the validation of Alzheimer's diagnostic biomarkers: methodological update Boccardi, Marina; Dodich, Alessandra; Albanese, Emiliano; Gayet-Ageron, Angèle; ... Garibotto, Valentina 2021